Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2408941, 12 pages
https://doi.org/10.1155/2017/2408941
Research Article

Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis

1Department of Clinical and Biological Sciences, AOU San Luigi Gonzaga, University of Torino, Orbassano, Torino, Italy
2Department of Veterinary Sciences, University of Torino, Grugliasco, Torino, Italy

Correspondence should be addressed to A. Roetto; ti.otinu@otteor.allenotna

Received 7 September 2016; Revised 1 March 2017; Accepted 4 April 2017; Published 2 May 2017

Academic Editor: Francesco Onida

Copyright © 2017 R. M. Pellegrino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Camaschella and A. Roetto, “TFR2-related hereditary hemochromatosis,” in GeneReviews, R. A. Pagon, M. P. Adam, H. H. Ardinger et al., Eds., University of Washington, Seattle, WA, USA, 2014. View at Google Scholar
  2. C. Camaschella, A. Roetto, A. Calì et al., “The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22,” Nature Genetics, vol. 25, no. 1, pp. 14–15, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Kawabata, R. Yang, T. Hirama et al., “Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family,” Journal of Biological Chemistry, vol. 274, no. 30, pp. 20826–20832, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. R. E. Fleming, M. C. Migas, C. C. Holden et al., “Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 5, pp. 2214–2219, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. M. U. Muckenthaler, B. Galy, and M. W. Hentze, “Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network,” Annual Review of Nutrition, vol. 28, pp. 197–213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Chen, J. Wang, K. R. Meyers, and C. A. Enns, “Transferrin-directed internalization and cycling of transferrin receptor 2,” Traffic, vol. 10, no. 10, pp. 1488–1501, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. W. Hentze, M. U. Muckenthaler, B. Galy, and C. Camaschella, “Two to tango: regulation of mammalian iron metabolism,” Cell, vol. 142, no. 1, pp. 24–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Roetto, F. Di Cunto, R. M. Pellegrino et al., “Comparison of 3 Tfr2-deficient murine models suggests distinct functions for Tfr2-α and Tfr2-β isoforms in different tissues,” Blood, vol. 115, no. 16, pp. 3382–3389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Roetto, A. Totaro, A. Piperno et al., “New mutations inactivating transferrin receptor 2 in hemochromatosis type 3,” Blood, vol. 97, no. 9, pp. 2555–2560, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Majore, F. Milano, F. Binni et al., “Homozygous p.M172K mutation of the TFR2 gene in an Italian family with type 3 hereditary hemochromatosis and early onset iron overload,” Haematologica, vol. 91, 8, Article ID ECR33, 2006. View at Google Scholar
  11. H. Forejtnikovà, M. Vieillevoye, Y. Zermati et al., “Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis,” Blood, vol. 116, no. 24, pp. 5357–5367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Nai, R. M. Pellegrino, M. Rausa et al., “The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice,” Haematologica, vol. 99, no. 6, pp. 1016–1021, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. D. F. Wallace, E. S. Secondes, G. Rishi et al., “A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction,” British Journal of Haematology, vol. 168, no. 6, pp. 891–901, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Troussard, S. Vol, E. Cornet et al., “Full blood count normal reference values for adults in France,” Journal of Clinical Pathology, vol. 67, no. 4, pp. 341–344, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Kautz, G. Jung, E. V. Valore, S. Rivella, E. Nemeth, and T. Ganz, “Identification of erythroferrone as an erythroid regulator of iron metabolism,” Nature Genetics, vol. 46, no. 7, pp. 678–684, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Kautz, G. Jung, E. Nemeth, and T. Ganz, “Erythroferrone contributes to recovery from anemia of inflammation,” Blood, vol. 124, no. 16, pp. 2569–2574, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Liu, R. Pop, C. Sadegh, C. Brugnara, V. H. Haase, and M. Socolovsky, “Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo,” Blood, vol. 108, no. 1, pp. 123–133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. H.-C. Chu, H.-Y. Lee, Y.-S. Huang et al., “Erythroid differentiation is augmented in Reelin-deficient K562 cells and homozygous reeler mice,” FEBS Letters, vol. 588, no. 1, pp. 58–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. L. Chen, T. D. Logan, M. L. Hochberg et al., “Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction,” Blood, vol. 114, no. 19, pp. 4045–4053, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. U. Testa, “Apoptotic mechanisms in the control of erythropoiesis,” Leukemia, vol. 18, no. 7, pp. 1176–1199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Silva, A. Benito, C. Sanz et al., “Erythropoietin can induce the expression of Bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines,” Journal of Biological Chemistry, vol. 274, no. 32, pp. 22165–22169, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. Beard, “Iron requirements in adolescent females,” The Journal of Nutrition, vol. 130, pp. 440S–442S, 2000. View at Google Scholar
  24. J. M. Guralnik, R. S. Eisenstaedt, L. Ferrucci, H. G. Klein, and R. C. Woodman, “Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia,” Blood, vol. 104, no. 8, pp. 2263–2268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Nilsson-Ehle, R. Jagenburg, S. Landahl, and A. Svanborg, “Blood haemoglobin declines in the elderly: implications for reference intervals from age 70 to 88,” European Journal of Haematology, vol. 65, no. 5, pp. 297–305, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Silvestri, A. Nai, A. Pagani, and C. Camaschella, “The extrahepatic role of TFR2 in iron homeostasis,” Frontiers in Pharmacology, vol. 5, p. 93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. M. B. Johnson, J. Chen, N. Murchison, F. A. Green, and C. A. Enns, “Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway,” Molecular Biology of the Cell, vol. 18, no. 3, pp. 743–754, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Nai, M. R. Lidonnici, M. Rausa et al., “The second transferrin receptor regulates red blood cell production in mice,” Blood, vol. 125, no. 7, pp. 1170–1179, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. S. D. Nimer, “Myelodysplastic syndromes,” Blood, vol. 111, no. 10, pp. 4841–4851, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Messa, D. Cilloni, F. Messa, F. Arruga, A. Roetto, and G. Saglio, “Deferasirox treatment improved the hemoglobin level and decreased transfusion requirements in four patients with the myelodysplastic syndrome and primary myelofibrosis,” Acta Haematologica, vol. 120, no. 2, pp. 70–74, 2008. View at Publisher · View at Google Scholar · View at Scopus